SG3 Management, LLC - CONSTELLATION PHARMCETICLS I ownership

Quarter-by-quarter ownership
SG3 Management, LLC ownership history of CONSTELLATION PHARMCETICLS I
ValueSharesWeighting
Q2 2021$426,000
-87.6%
12,600
-91.4%
0.02%
-82.6%
Q1 2021$3,438,000147,0000.09%
Other shareholders
CONSTELLATION PHARMCETICLS I shareholders Q3 2021
NameSharesValueWeighting ↓
Ponoi II Management, LLC 1,574,229$36,821,00028.20%
Ponoi Management, LLC 1,880,623$43,988,00025.87%
VR Adviser, LLC 4,016,873$93,955,00010.19%
Column Group LLC 2,626,631$61,437,0005.89%
Euclidean Capital LLC 554,325$12,966,0004.34%
GREAT POINT PARTNERS LLC 872,415$20,406,0004.22%
Venrock Management V, LLC 1,570,058$36,724,0003.76%
COMMODORE CAPITAL LP 368,448$8,618,0003.43%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 621,541$14,538,0001.90%
Bain Capital Life Sciences Investors, LLC 1,400,000$32,746,0001.86%
View complete list of CONSTELLATION PHARMCETICLS I shareholders